Health ❯ Healthcare ❯ Pharmaceuticals

Drug Safety

Mifepristone Counterfeit Medications Medication Recall Product Recalls Contaminated Drugs Quality Control Adverse Effects Product Recall Side Effects Contaminated Medications

FDA Classifies Chlorthalidone Recall as Class II

The classification flags possible short-term health effects, prompting closer FDA review of generic dissolution testing.

Nationwide Recall of 25 mg Chlorthalidone Covers 11,460 Bottles

More Than 370,000 Duloxetine Bottles Recalled Over Nitrosamine Contamination

Neumora Halts Navacaprant After Phase 3 KOASTAL Failures

FDA Orders New Kidney Warning for Orlistat Weight‑Loss Pills

Haleon Recalls Four Lots of Gas‑X Extra Strength Softgels

FDA Launches Retrospective Safety Study of Mifepristone

EMA Recommends Etcamah for ESR1‑Mutant Advanced Breast Cancer

Japan Orders Warning for Tabneos After 20 Deaths Linked to Liver Dysfunction

Kissei Discloses 20 Deaths in Japan Among Tabneous Users

Kissei Tells Japan Doctors to Halt New Tavneos Use After 20 Deaths Reported

MHRA Tightens Finasteride Safety Warnings, Adds Precaution for Dutasteride

French Drug Regulator Fines Novo Nordisk and Eli Lilly Over Obesity Drug Promotions

FDA Proposes Blocking Bulk Compounding of GLP-1 Drugs by Outsourcing Facilities

Peru’s Drug Regulator Orders Recall and Destruction of Two Medicine Lots Over Safety Failures

Peru’s Digemid Recalls AZAGLOB Azathioprine Lot After Failed Content Test

Gurugram Bust Exposes Counterfeit Mounjaro Operation With Suspected China Link

UK Orders Class 2 Recall of Ramipril 10mg Batch Over Mispacked 5mg Strips

Peru Orders Recall and Destruction of Gentabiot Injection Lot Over Safety Defect

Gurugram Bust Seizes 242 Suspected Fake Mounjaro Pens, Two Arrested